Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data

Wong, J
Law, S

January 2001

Accurate pretherapy staging for esophageal cancer is important for stage-directed therapy. Precise s...

Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase III Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08).

von Holzen, U.
Schmidt, S.
Hayoz, S.
Steffen, T.
Grieder, F.
Bartsch, D.
Schnider, A.
Knoefel, W.T.
Piessen, G.
Kettelhack, C.
Marti, W.R.
Schäfer, M.
Függer, R.
Köigsrainer, A.
Gloor, B.
Furrer, M.
Gérard, M.A.
Hawle, H.
Walz, M.K.
Alesina, P.
Ruhstaller, T.

June 2022

To assess the impact of surgical technique in regard to morbidity and mortality after neoadjuvant tr...

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

Sicong Hou
Ziyin Pan
Xin Hao
Qinglei Hang
Yanbing Ding

October 2021

Neoadjuvant therapies, primarily chemotherapy and chemoradiotherapy, are able to improve the overall...

Worldwide Esophageal Cancer Collaboration: clinical staging data

Rice, T. W.
Apperson‐hansen, C.
DiPaola, L. M.
Semple, M. E.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L.‐q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. N.
Davies, A. R.
D’Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Räsänen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J.‐f.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.
Denlinger, C. E.
Schipper, P. H.
Ishwaran, H.
Blackstone, E. H.

October 2016

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134482/1/dote12493.pdfhttp://deepblue.l...

Worldwide Esophageal Cancer Collaboration: pathologic staging data

Rice, T. W.
Chen, L.‐q.
Hofstetter, W. L.
Smithers, B.M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. L.
Davies, A. R.
D’Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Räsänen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Cecconello, I.
Allum, W. H.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J.‐f.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.
Denlinger, C. E.
Schipper, P. H.
Lerut, T. E. M. R.
Orringer, M. B.
Ishwaran, H.
Apperson‐hansen, C.
DiPaola, L. M.
Semple, M. E.
Blackstone, E. H.

October 2016

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134420/1/dote12520_am.pdfhttp://deepblu...

Worldwide esophageal cancer collaboration: neoadjuvant pathologic staging data

Rice, T. W.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L. -Q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
van Lanschot, J.
Chen, K. N.
Davies, A. R.
D'Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Rasanen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J. -F.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.

October 2016

To address uncertainty of whether pathologic stage groupings after neoadjuvant therapy (ypTNM) for e...

Worldwide Esophageal Cancer Collaboration: pathologic staging data.

Rice, T.W.
Pera Roman, Manuel Ramón
Blackstone, Eugene H.

January 2016

We report data-simple descriptions of patient characteristics, cancer categories, and non-risk-adjus...

Worldwide esophageal cancer collaboration

Law, S
Watson, TJ
Hunter, JG
Kesler, KA
Lerut, TEMR
Reed, CE
Salo, JA
Scott, WJ
Swisher, SG
Blackstone, EH
Rice, TW
Rusch, VW
AppersonHansen, C
Allen, MS
Chen, LQ

January 2009

The aim of this study is to report assemblage of a large multi-institutional international database ...

Worldwide esophageal cancer collaboration: clinical staging data

Rice, T. W.
Apperson-Hansen, C.
DiPaola, L. M.
Semple, M. E.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L. -Q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. N.
Davies, A. R.
D'Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Rasanen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J. -F.
Allen, M. S.
Law, S.
Watson, T. J.

October 2016

To address uncertainty of whether clinical stage groupings (cTNM) for esophageal cancer share progno...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E. M.
Bergman, J. J.
Bartels-Rutten, A.
ter Beek, L. C.
Beets-Tan, R. G. H.
Bennink, R. J.
Henegouwen, M. I. van Berge
Brosens, L. A. A.
Defize, I. L.
van Dieren, J. M.
Dijkstra, H.
van Hillegersberg, R.
Hulshof, M. C.
van Laarhoven, H. W. M.
Lam, M. G. E. H.
van Lier, A. L. H. M. W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T. M.
van Rossum, P. S. N.
Ruurda, J. P.
van Sandick, J. W.
Weusten, B. L. A. M.
Voncken, F. E. M.
Yakar, D.
Meijer, G. J.

October 2018

BackgroundNearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally a...

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?

Sebahattin Celik
Remzi Erten
Abdulsamed Batur
Burak Suvak

January 2015

Background. Since neoadjuvant treatment in esophageal cancer began to become popular, a complete pat...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE) : A multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E.M.
Bergman, J. J.
Bartels-Rutten, A.
Ter Beek, L. C.
Beets-Tan, R. G.H.
Bennink, R. J.
Van Berge Henegouwen, M. I.
Brosens, L. A.A.
Defize, I. L.
Van Dieren, J. M.
Dijkstra, H.
Van Hillegersberg, R.
Hulshof, M. C.
Van Laarhoven, H. W.M.
Lam, M. G.E.H.
Van Lier, A. L.H.M.W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T.M.
Van Rossum, P. S.N.
Ruurda, J. P.
Van Sandick, J. W.
Weusten, B. L.A.M.
Voncken, F. E.M.
Yakar, D.
Meijer, G. J.
Aleman, B. M.P.
Borra, R. J.H.
Van Etten, B.
Gisbertz, S. S.
Goense, L.
Haj Mohammad, N.
Hartemink, K. J.
Kappert, P.
Kats-Ugurlu, G.
Kodach, L. L.
Korteweg, T.
Krishnadath, K. K.
Langendijk, J. A.
De Leng, W. W.J.
Meijer, S. L.
Potze, J. H.
Stoker, J.
Vegt, E.
Verkooijen, H. M.
Vollenbrock, S. E.
Wessels, F.

October 2018

Background: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally...

Assessing downgrading of esophageal adenocarcinoma after neoadjuvant chemotherapy: a case report Indrasto Histopaedianto1, Adeodatus Yuda Handaya2*, Hendro Wartatmo2

Adeodatus Yuda Handaya
Indrasto Histopaedianto
Hendro Wartatmo

February 2017

Esophageal carcinoma, squamous cell carcinoma, and adenocarcinoma, are a deadly serious malignancy. ...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E. M.
Bergman, J. J.
Bartels-Rutten, A.
ter Beek, L. C.
Beets-Tan, R. G. H.
Bennink, R. J.
van Berge Henegouwen, M. I.
Brosens, L. A. A.
Defize, I. L.
van Dieren, J. M.
Dijkstra, H.
van Hillegersberg, R.
Hulshof, M. C.
van Laarhoven, H. W. M.
Lam, M. G. E. H.
van Lier, A. L. H. M. W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T. M.
van Rossum, P. S. N.
Ruurda, J. P.
van Sandick, J. W.
Weusten, B. L. A. M.
Voncken, F. E. M.
Yakar, D.
Meijer, G. J.
Aleman, B. M. P.
Borra, R. J. H.
van Etten, B.
Gisbertz, S. S.
Goense, L.
Haj Mohammad, N.
Hartemink, K. J.
Kappert, P.
Kats-Ugurlu, G.
Kodach, L. L.
Korteweg, T.
Krishnadath, K. K.
Langendijk, J. A.
de Leng, W. W. J.
Meijer, S. L.
Potze, J. H.
Stoker, J.
Vegt, E.
Verkooijen, H. M.
Vollenbrock, S. E.
Wessels, F.

January 2018

Background: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally...

Case Report A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after

Neoadjuvant Therapy
Sebahattin Celik
Remzi Erten
Abdulsamed Batur
Burak Suvak

January 2015

Esophageal cancer

Wong, J
Law, S

January 2001

Accurate pretherapy staging for esophageal cancer is important for stage-directed therapy. Precise s...

Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase III Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08).

von Holzen, U.
Schmidt, S.
Hayoz, S.
Steffen, T.
Grieder, F.
Bartsch, D.
Schnider, A.
Knoefel, W.T.
Piessen, G.
Kettelhack, C.
Marti, W.R.
Schäfer, M.
Függer, R.
Köigsrainer, A.
Gloor, B.
Furrer, M.
Gérard, M.A.
Hawle, H.
Walz, M.K.
Alesina, P.
Ruhstaller, T.

June 2022

To assess the impact of surgical technique in regard to morbidity and mortality after neoadjuvant tr...

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

Sicong Hou
Ziyin Pan
Xin Hao
Qinglei Hang
Yanbing Ding

October 2021

Neoadjuvant therapies, primarily chemotherapy and chemoradiotherapy, are able to improve the overall...

Worldwide Esophageal Cancer Collaboration: clinical staging data

Rice, T. W.
Apperson‐hansen, C.
DiPaola, L. M.
Semple, M. E.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L.‐q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. N.
Davies, A. R.
D’Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Räsänen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J.‐f.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.
Denlinger, C. E.
Schipper, P. H.
Ishwaran, H.
Blackstone, E. H.

October 2016

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134482/1/dote12493.pdfhttp://deepblue.l...

Worldwide Esophageal Cancer Collaboration: pathologic staging data

Rice, T. W.
Chen, L.‐q.
Hofstetter, W. L.
Smithers, B.M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. L.
Davies, A. R.
D’Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Räsänen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Cecconello, I.
Allum, W. H.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J.‐f.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.
Denlinger, C. E.
Schipper, P. H.
Lerut, T. E. M. R.
Orringer, M. B.
Ishwaran, H.
Apperson‐hansen, C.
DiPaola, L. M.
Semple, M. E.
Blackstone, E. H.

October 2016

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134420/1/dote12520_am.pdfhttp://deepblu...

Worldwide esophageal cancer collaboration: neoadjuvant pathologic staging data

Rice, T. W.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L. -Q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
van Lanschot, J.
Chen, K. N.
Davies, A. R.
D'Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Rasanen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J. -F.
Allen, M. S.
Law, S.
Watson, T. J.
Darling, G. E.
Scott, W. J.
Duranceau, A.

October 2016

To address uncertainty of whether pathologic stage groupings after neoadjuvant therapy (ypTNM) for e...

Worldwide Esophageal Cancer Collaboration: pathologic staging data.

Rice, T.W.
Pera Roman, Manuel Ramón
Blackstone, Eugene H.

January 2016

We report data-simple descriptions of patient characteristics, cancer categories, and non-risk-adjus...

Worldwide esophageal cancer collaboration

Law, S
Watson, TJ
Hunter, JG
Kesler, KA
Lerut, TEMR
Reed, CE
Salo, JA
Scott, WJ
Swisher, SG
Blackstone, EH
Rice, TW
Rusch, VW
AppersonHansen, C
Allen, MS
Chen, LQ

January 2009

The aim of this study is to report assemblage of a large multi-institutional international database ...

Worldwide esophageal cancer collaboration: clinical staging data

Rice, T. W.
Apperson-Hansen, C.
DiPaola, L. M.
Semple, M. E.
Lerut, T. E. M. R.
Orringer, M. B.
Chen, L. -Q.
Hofstetter, W. L.
Smithers, B. M.
Rusch, V. W.
Wijnhoven, B. P. L.
Chen, K. N.
Davies, A. R.
D'Journo, X. B.
Kesler, K. A.
Luketich, J. D.
Ferguson, M. K.
Rasanen, J. V.
van Hillegersberg, R.
Fang, W.
Durand, L.
Allum, W. H.
Cecconello, I.
Cerfolio, R. J.
Pera, M.
Griffin, S. M.
Burger, R.
Liu, J. -F.
Allen, M. S.
Law, S.
Watson, T. J.

October 2016

To address uncertainty of whether clinical stage groupings (cTNM) for esophageal cancer share progno...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E. M.
Bergman, J. J.
Bartels-Rutten, A.
ter Beek, L. C.
Beets-Tan, R. G. H.
Bennink, R. J.
Henegouwen, M. I. van Berge
Brosens, L. A. A.
Defize, I. L.
van Dieren, J. M.
Dijkstra, H.
van Hillegersberg, R.
Hulshof, M. C.
van Laarhoven, H. W. M.
Lam, M. G. E. H.
van Lier, A. L. H. M. W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T. M.
van Rossum, P. S. N.
Ruurda, J. P.
van Sandick, J. W.
Weusten, B. L. A. M.
Voncken, F. E. M.
Yakar, D.
Meijer, G. J.

October 2018

BackgroundNearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally a...

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?

Sebahattin Celik
Remzi Erten
Abdulsamed Batur
Burak Suvak

January 2015

Background. Since neoadjuvant treatment in esophageal cancer began to become popular, a complete pat...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE) : A multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E.M.
Bergman, J. J.
Bartels-Rutten, A.
Ter Beek, L. C.
Beets-Tan, R. G.H.
Bennink, R. J.
Van Berge Henegouwen, M. I.
Brosens, L. A.A.
Defize, I. L.
Van Dieren, J. M.
Dijkstra, H.
Van Hillegersberg, R.
Hulshof, M. C.
Van Laarhoven, H. W.M.
Lam, M. G.E.H.
Van Lier, A. L.H.M.W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T.M.
Van Rossum, P. S.N.
Ruurda, J. P.
Van Sandick, J. W.
Weusten, B. L.A.M.
Voncken, F. E.M.
Yakar, D.
Meijer, G. J.
Aleman, B. M.P.
Borra, R. J.H.
Van Etten, B.
Gisbertz, S. S.
Goense, L.
Haj Mohammad, N.
Hartemink, K. J.
Kappert, P.
Kats-Ugurlu, G.
Kodach, L. L.
Korteweg, T.
Krishnadath, K. K.
Langendijk, J. A.
De Leng, W. W.J.
Meijer, S. L.
Potze, J. H.
Stoker, J.
Vegt, E.
Verkooijen, H. M.
Vollenbrock, S. E.
Wessels, F.

October 2018

Background: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally...

Assessing downgrading of esophageal adenocarcinoma after neoadjuvant chemotherapy: a case report Indrasto Histopaedianto1, Adeodatus Yuda Handaya2*, Hendro Wartatmo2

Adeodatus Yuda Handaya
Indrasto Histopaedianto
Hendro Wartatmo

February 2017

Esophageal carcinoma, squamous cell carcinoma, and adenocarcinoma, are a deadly serious malignancy. ...

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study

Borggreve, A. S.
Mook, S.
Verheij, M.
Mul, V. E. M.
Bergman, J. J.
Bartels-Rutten, A.
ter Beek, L. C.
Beets-Tan, R. G. H.
Bennink, R. J.
van Berge Henegouwen, M. I.
Brosens, L. A. A.
Defize, I. L.
van Dieren, J. M.
Dijkstra, H.
van Hillegersberg, R.
Hulshof, M. C.
van Laarhoven, H. W. M.
Lam, M. G. E. H.
van Lier, A. L. H. M. W.
Muijs, C. T.
Nagengast, W. B.
Nederveen, A. J.
Noordzij, W.
Plukker, J. T. M.
van Rossum, P. S. N.
Ruurda, J. P.
van Sandick, J. W.
Weusten, B. L. A. M.
Voncken, F. E. M.
Yakar, D.
Meijer, G. J.
Aleman, B. M. P.
Borra, R. J. H.
van Etten, B.
Gisbertz, S. S.
Goense, L.
Haj Mohammad, N.
Hartemink, K. J.
Kappert, P.
Kats-Ugurlu, G.
Kodach, L. L.
Korteweg, T.
Krishnadath, K. K.
Langendijk, J. A.
de Leng, W. W. J.
Meijer, S. L.
Potze, J. H.
Stoker, J.
Vegt, E.
Verkooijen, H. M.
Vollenbrock, S. E.
Wessels, F.

January 2018

Background: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally...

Case Report A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after

Neoadjuvant Therapy
Sebahattin Celik
Remzi Erten
Abdulsamed Batur
Burak Suvak

January 2015

Esophageal cancer

Wong, J
Law, S

January 2001

Accurate pretherapy staging for esophageal cancer is important for stage-directed therapy. Precise s...

Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase III Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08).

von Holzen, U.
Schmidt, S.
Hayoz, S.
Steffen, T.
Grieder, F.
Bartsch, D.
Schnider, A.
Knoefel, W.T.
Piessen, G.
Kettelhack, C.
Marti, W.R.
Schäfer, M.
Függer, R.
Köigsrainer, A.
Gloor, B.
Furrer, M.
Gérard, M.A.
Hawle, H.
Walz, M.K.
Alesina, P.
Ruhstaller, T.

June 2022

To assess the impact of surgical technique in regard to morbidity and mortality after neoadjuvant tr...

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

Sicong Hou
Ziyin Pan
Xin Hao
Qinglei Hang
Yanbing Ding

October 2021

Neoadjuvant therapies, primarily chemotherapy and chemoradiotherapy, are able to improve the overall...

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data

Abstract

Extracted data

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data

Abstract

Extracted data

Related items

Related items